PhenoVista Biosciences Partners with FUJIFILM Cellular Dynamics to Develop New Applications and Services in hiPSC Drug Discovery

January 7, 2022 9:00 AM / by PhenoVista Biosciences

SAN DIEGO, California – PhenoVista Biosciences, LLC and FUJIFILM Cellular Dynamics, Inc. (FCDI) announce a new collaboration to broaden and enhance drug discovery with human induced pluripotent stem cells (hiPSC) by combining PhenoVista’s drug discovery and assay-development services with FCDI’s portfolio of cellular models and products. This partnership will develop applications of new FCDI products and offer US-based, custom analytical services to advance drug-discovery technologies using hiPSC.

The alliance between PhenoVista and FCDI will afford new strategies and systems with which scientists can accelerate biological and pharmacological research by harnessing the versatility of hiPSC to better understand human health and disease, with the ultimate goal of improving healthcare and treatment options and enhancing patients’ quality of life.

About FUJIFILM Cellular Dynamics, Inc.

FUJIFILM Cellular Dynamics, Inc. is a leading developer and manufacturer of human induced pluripotent stem cells (hiPSCs) utilized in drug discovery and cell therapies. The pre-clinical stage company is using its expertise in hiPSC technologies to develop a robust pipeline of cell therapeutics candidates. For its partners, FCDI utilizes its hiPSC platform to advance the progress of therapeutic candidates in the clinic and provides contract development and manufacturing (CDMO) services. In addition to cell therapy, FCDI also offers life science research tools including the company’s inventoried iCell® products that are available in many cell types and sourced from multiple cell lines which can be applied for target identification as well as toxicity testing. The company also offers custom cell services and cell banking. FCDI’s goal is to leverage the vast utility of hiPSCs to advance human health and improve the quality of life for patients around the world. For more information, please visit:


Christine Jackman
FUJIFILM Holdings America Corporation
914 261 4959

About PhenoVista Biosciences

PhenoVista Biosciences is a leading provider of customized, imaging-based, phenotypic assay services based in San Diego, California. PhenoVista has built a strong reputation on providing high-quality data with a collaborative, adaptable nature of engagement to biopharmaceutical clients that range from local start-ups to global organizations. With its unique and unparalleled expertise in combining the cutting-edge quantitative imaging technologies and data-analysis capabilities, PhenoVista works with its clients to design, create, and implement high-throughput, high-content assays in myriad in vitro systems. Their diverse repertoire includes working with primary cells, iPSC-derived neurons, and client-engineered lines in 2D, 3D, co-culture, and microfluidic systems to construct myriad functional, structural, and pre-clinical, therapeutic assays.

For more information, please visit Follow PhenoVista on  LinkedInTwitter, and Facebook.


James Evans, PhD
PhenoVista Biosciences, LLC.

Scroll to Top